Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.73 +0.14 (+1.84%)
At close: Oct 21, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Times Interest Earned (2023 - 2024)

Updated

Eupraxia Pharmaceuticals' (EPRX) Times Interest Earned stood at -54968.43 in the quarter ended Dec 31, 2024.

Analysis

Eupraxia Pharmaceuticals (EPRX) Times Interest Earned (2023 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Eupraxia Pharmaceuticals' Times Interest Earned came in at -43.65.

  • Across earlier years, Times Interest Earned came in at -25.72 in the year ended Dec 31, 2023 and -20.32 in the year ended Dec 31, 2022.
  • Per Business Quant, the preceding three quarters came in at -13285.52 (quarter ended Sep 30, 2024), -22.53 (quarter ended Jun 30, 2024) and -20.16 (quarter ended Mar 31, 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Eupraxia Pharmaceuticals 308.46 Mn -133.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -5.24
Sep 30, 2024 -13,285.52
Jun 30, 2024 -22.53
Mar 31, 2024 -20.16
Jun 30, 2023 -32.50
Mar 31, 2023 -14.57
API Access

Eupraxia Pharmaceuticals Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=EPRX&period=max&api_key=YOUR_API_KEY